Related Experiment Video
Updated: Jul 6, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Absence of motilin gene mutations in infantile hypertrophic pyloric stenosis
Anna Svenningsson1, Kristina Lagerstedt, Mir Davood Omrani
1Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 76 Stockholm, Sweden.
Insights
Mutations in the motilin gene (MLN) do not appear to cause infantile hypertrophic pyloric stenosis (IHPS). Researchers found no significant association between MLN variants and IHPS risk.
Area of Science:
- Genetics
- Pediatric Gastroenterology
- Molecular Biology
Background:
- Erythromycin use in infants under two weeks increases infantile hypertrophic pyloric stenosis (IHPS) risk up to tenfold.
- Erythromycin acts as a motilin agonist, influencing gastrointestinal motility.
Purpose of the Study:
- To investigate if mutations in the motilin gene (MLN) are a cause of IHPS.
- To determine if the V15A polymorphism in the MLN is associated with IHPS.
Main Methods:
- Screened the MLN for mutations and determined V15A polymorphism in 57 IHPS patients.
- Utilized polymerase chain reaction and DNA sequencing.
- Compared genotype and allele frequencies with 184 controls.
Main Results:
- Detected 3 novel MLN sequence variants in 4 patients; one caused an amino acid change (A25G).
- All detected variants were also found in controls or not inherited with IHPS.
- No significant association was found between the V15A polymorphism and IHPS.
Conclusions:
- The coding region of the MLN is excluded as a primary cause of IHPS.
- Further research is needed to understand the role of the motilin pathway in IHPS pathogenesis.
Background:
Erythromycin treatment before 2 weeks of age has been shown to increase the risk of infantile hypertrophic pyloric stenosis (IHPS) up to 10 times. Erythromycin is a motilin agonist, a hormone that induces gastrointestinal contractions. The purpose of this study was to investigate if mutations in the motilin gene (MLN) cause IHPS or if the V15A polymorphism in MLN is associated with the disease.
Methods:
The MLN was screened for mutations, and the V15A polymorphism was determined in a total of 57 patients with IHPS using polymerase chain reaction and DNA sequencing. The polymorphism genotype and allele frequencies among the patients were compared with 184 controls.
Results:
We detected 3 different, not previously reported, MLN sequence variants in 4 patients. One of these variants results in an amino acid exchange in the motilin signal peptide (A25G). All 3 detected sequence variants were also found in controls or were not inherited with the disease. We found no significant association between the V15A polymorphism and the disease.
Conclusions:
We have excluded the MLN coding region as a major cause of IHPS. Future studies will evaluate the importance of this metabolic pathway in the pathogenesis of IHPS.
Related Concept Videos
Pyloric Obstruction
Gastrointestinal Motility Disorders
Gastric Motility
Peristaltic Waves and Chyme Formation
Upon food entry, the stomach initiates...
Gastritis II: Pathophysiology
Esophageal Achalasia
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...

